Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Charlotte Sorieul, Marta Dolce, Maria Rosaria Romano, Jeroen Codée & Roberto Adamo. (2023) Glycoconjugate vaccines against antimicrobial resistant pathogens. Expert Review of Vaccines 22:1, pages 1055-1078.
Read now
Read now
Chih-Ming Tsai, Jr Caldera, Irshad A. Hajam & George Y. Liu. (2023) Toward an effective Staphylococcus vaccine: why have candidates failed and what is the next step?. Expert Review of Vaccines 22:1, pages 207-209.
Read now
Read now
Alessandra Ferraro, Sofia M. Buonocore, Philippe Auquier, Isabelle Nicolas, Hugues Wallemacq, Dominique Boutriau & Robbert G. van der Most. (2019) Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus. Human Vaccines & Immunotherapeutics 15:12, pages 2980-2992.
Read now
Read now
Shamshul Ansari, Rajesh Kumar Jha, Shyam Kumar Mishra, Birendra Raj Tiwari & Ahmed Morad Asaad. (2019) Recent advances in Staphylococcus aureus infection: focus on vaccine development. Infection and Drug Resistance 12, pages 1243-1255.
Read now
Read now
A. Gurtman, E. Begier, N. Mohamed, J. Baber, C. Sabharwal, R.M. Haupt, H. Edwards, D. Cooper, K.U. Jansen & A.S. Anderson. (2019) The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery. Human Vaccines & Immunotherapeutics 15:2, pages 358-370.
Read now
Read now
Megumi Inoue, Takuma Yonemura, James Baber, Yasuko Shoji, Masakazu Aizawa, David Cooper, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson & Alejandra Gurtman. (2018) Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults. Human Vaccines & Immunotherapeutics 14:11, pages 2682-2691.
Read now
Read now
Amandine Gagneux-Brunon, Frédéric Lucht, Odile Launay, Philippe Berthelot & Elisabeth Botelho-Nevers. (2018) Vaccines for healthcare-associated infections: present, future, and expectations. Expert Review of Vaccines 17:5, pages 421-433.
Read now
Read now
Fabio Bagnoli. (2017) Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines. Virulence 8:7, pages 1037-1042.
Read now
Read now
Bo Liu, Saeyoung Park, Christopher D. Thompson, Xue Li & Jean C. Lee. (2017) Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo. Virulence 8:6, pages 859-874.
Read now
Read now
Brian L. Cheng, Travis B. Nielsen, Paul Pantapalangkoor, Fan Zhao, Jean C. Lee, Christopher P. Montgomery, Brian Luna, Brad Spellberg & Robert S. Daum. (2017) Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection. Human Vaccines & Immunotherapeutics 13:7, pages 1609-1614.
Read now
Read now
Andreas Roetzer, Bernd Jilma & Martha M. Eibl. (2017) Vaccine against toxic shock syndrome in a first-in-man clinical trial. Expert Review of Vaccines 16:2, pages 81-83.
Read now
Read now
Gustavo H. Dayan, Naglaa Mohamed, Ingrid L. Scully, David Cooper, Elizabeth Begier, Joseph Eiden, Kathrin U. Jansen, Alejandra Gurtman & Annaliesa S. Anderson. (2016) Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Review of Vaccines 15:11, pages 1373-1392.
Read now
Read now
Cuong Vuong, Anthony J. Yeh, Gordon YC Cheung & Michael Otto. (2016) Investigational drugs to treat methicillin-resistant Staphylococcus aureus. Expert Opinion on Investigational Drugs 25:1, pages 73-93.
Read now
Read now
Articles from other publishers (90)
Joshua T Thaden, Richard Ahn, Felicia Ruffin, David W Gjertson, Alexander Hoffmann, Vance G FowlerJrJr & Michael R Yeaman. (2023) Use of Transcriptional Signatures to Differentiate Pathogen-Specific and Treatment-Specific Host Responses in Patients With Bacterial Bloodstream Infections. The Journal of Infectious Diseases.
Crossref
Crossref
Guangzong Tian, Chunjun Qin, Jing Hu, Xiaopeng Zou & Jian Yin. (2023) Effect of Side-Chain Functional Groups in the Immunogenicity of Bacterial Surface Glycans. Molecules 28:20, pages 7112.
Crossref
Crossref
Yanhao Zhang, Feng Yang, Dong Sun, Limin Xu, Yaojia Shi, Leilei Qin, Liqun Zhao, Liting Wang, Wei Sun, Hongri Wu, Dongshui Lu, Weijun Zhang, Ping luo, Ping Cheng, Quanming Zou & Hao Zeng. (2023) rFSAV promotes Staphylococcus aureus-infected bone defect healing via IL-13- mediated M2 macrophage polarization. Clinical Immunology 255, pages 109747.
Crossref
Crossref
Hamid Hassanzadeh, James Baber, Elizabeth Begier, David C Noriega, Hiroaki Konishi, Yoshiyuki Yato, Michael Y Wang, Jean Charles Le Huec, Vikas Patel, Peter Varga, Ulf Liljenqvist, John Conly, Charu Sabharwal, Iona Munjal, David Cooper, David Radley, Anna Jaques, Michael Patton, William C Gruber, Kathrin U Jansen, Annaliesa S Anderson, Alejandra Gurtman, Jonathan Zenilman, Robert Salata, William Schaffner, William Blackwelder & David Leaper. (2023)
Efficacy of a 4-Antigen
Staphylococcus aureus
Vaccine in Spinal Surgery: The
STaphylococcus aureus
suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
. Clinical Infectious Diseases 77:2, pages 312-320.
Crossref
Crossref
Hafsa Qadri, Abdul Haseeb Shah, Mustfa Alkhanani, Abdullah Almilaibary & Manzoor Ahmad Mir. (2023) Immunotherapies against human bacterial and fungal infectious diseases: A review. Frontiers in Medicine 10.
Crossref
Crossref
Enitan Omobolanle Adesanya & Akingbolabo Daniel Ogunlakin. 2023. Staphylococcal Infections - Recent Advances and Perspectives. Staphylococcal Infections - Recent Advances and Perspectives.
Vincenzo Costanzo & Giovanni N. Roviello. (2023) The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines 11:2, pages 333.
Crossref
Crossref
Asmat Ali, Abdul Waris, Muhammad Ajmal Khan, Muhammad Asim, Atta Ullah Khan, Sahrish Khan & Jehan Zeb. (2023) Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections. Life Sciences 314, pages 121332.
Crossref
Crossref
Pooi Yin Chung. (2023)
Immunotherapies for the prevention and treatment of
Staphylococcus aureus
infections: updates and challenges
. Pathogens and Disease 81.
Crossref
Crossref
Isaac Thomsen & C. Buddy Creech. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
710
723.e4
.
Jinzhou Ye & Xinhai Chen. (2022) Current Promising Strategies against Antibiotic-Resistant Bacterial Infections. Antibiotics 12:1, pages 67.
Crossref
Crossref
Gagneux-Brunon Amandine, Julie Gagnaire, Carole Pelissier, Berthelot Philippe & Botelho-Nevers Elisabeth. (2022) Vaccines for healthcare associated infections without vaccine prevention to date. Vaccine: X 11, pages 100168.
Crossref
Crossref
Chih-Ming Tsai, Irshad A. Hajam, J.R. Caldera & George Y. Liu. (2022) Integrating complex host-pathogen immune environments into S. aureus vaccine studies. Cell Chemical Biology 29:5, pages 730-740.
Crossref
Crossref
Severien Meyers, Marilena Crescente, Peter Verhamme & Kimberly Martinod. (2022)
Staphylococcus aureus
and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in Immunothrombosis
. Arteriosclerosis, Thrombosis, and Vascular Biology 42:3, pages 261-276.
Crossref
Crossref
Andrew J. R. Cooper, Jonah Clegg, Féaron C. Cassidy, Andrew E. Hogan & Rachel M. McLoughlin. (2022) Human MAIT Cells Respond to Staphylococcus aureus with Enhanced Anti-Bacterial Activity. Microorganisms 10:1, pages 148.
Crossref
Crossref
Masamitsu Kanada, Jordan C. Walker & Nureddin Ashammakhi. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
577
590
.
Yusra Habib Khan, Amna Saifullah & Tauqeer Hussain Mallhi. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
530
544
.
Narjes Noori Goodarzi, Negin Bolourchi, Sepideh Fereshteh, Armaghan Soltani Shirazi, Mohammad Reza Pourmand & Farzad Badmasti. (2021) Investigation of novel putative immunogenic targets against Staphylococcus aureus using a reverse vaccinology strategy. Infection, Genetics and Evolution 96, pages 105149.
Crossref
Crossref
Kathrin U. Jansen, William C. Gruber, Raphael Simon, James Wassil & Annaliesa S. Anderson. (2021) The impact of human vaccines on bacterial antimicrobial resistance. A review. Environmental Chemistry Letters 19:6, pages 4031-4062.
Crossref
Crossref
Enrico König, Assunta Gagliardi, Ilary Riedmiller, Chiara Andretta, Michele Tomasi, Carmela Irene, Luca Frattini, Ilaria Zanella, Francesco Berti, Alberto Grandi, Elena Caproni, Laura Fantappiè & Guido Grandi. (2021) Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case. Frontiers in Immunology 12.
Crossref
Crossref
Vandana Solanki, Monalisa Tiwari & Vishvanath Tiwari. (2021)
Subtractive proteomic analysis of antigenic extracellular proteins and design a multi‐epitope vaccine against
Staphylococcus aureus
. Microbiology and Immunology 65:8, pages 302-316.
Crossref
Crossref
Zhifu Chen, Qiang Gou, Qingshan Xiong, Lianli Duan, Yue Yuan, Jiang Zhu, Jintao Zou, Longlong Chen, Haiming Jing, Xiaoli Zhang, Ping Luo, Hao Zeng, Quanming Zou, Zhuo Zhao & Jinyong Zhang. (2021) Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia. Frontiers in Immunology 12.
Crossref
Crossref
Francesca Micoli, Fabio Bagnoli, Rino Rappuoli & Davide Serruto. (2021) The role of vaccines in combatting antimicrobial resistance. Nature Reviews Microbiology 19:5, pages 287-302.
Crossref
Crossref
Arundhathi Venkatasubramaniam, Grant Liao, Eunice Cho, Rajan P. Adhikari, Tom Kort, Frederick W. Holtsberg, Karen E. Elsass, Dean J. Kobs, Thomas L. RudgeJrJr, Keith D. Kauffman, Nickiana E. Lora, Daniel L. Barber, M. Javad Aman & Hatice Karauzum. (2021) Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques. Frontiers in Immunology 12.
Crossref
Crossref
Bonggoo Park & George Y. Liu. (2021) Immune-Based Anti-Staphylococcal Therapeutic Approaches. Microorganisms 9:2, pages 328.
Crossref
Crossref
Angela França, Vânia Gaio, Nathalie Lopes & Luís D. R. Melo. (2021) Virulence Factors in Coagulase-Negative Staphylococci. Pathogens 10:2, pages 170.
Crossref
Crossref
Ingrid L. Scully, Yekaterina Timofeyeva, Arthur Illenberger, Peimin Lu, Paul A. Liberator, Kathrin U. Jansen & Annaliesa S. Anderson. (2021) Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease. Microorganisms 9:1, pages 177.
Crossref
Crossref
Euzebiusz Jamrozik, George Heriot, Susan Bull & Michael Parker. (2021) Vaccine-enhanced disease: case studies and ethical implications for research and public health. Wellcome Open Research 6, pages 154.
Crossref
Crossref
Kathrin U. Jansen, William C. Gruber, Raphael Simon, James Wassil & Annaliesa S. Anderson. 2021. Sustainable Agriculture Reviews 49. Sustainable Agriculture Reviews 49
347
430
.
Erin Armentrout, George Liu & Gislâine Martins. (2020) T Cell Immunity and the Quest for Protective Vaccines against Staphylococcus aureus Infection. Microorganisms 8:12, pages 1936.
Crossref
Crossref
Andreas Roetzer, Norbert Stich, Nina Model, Michael Schwameis, Christa Firbas, Bernd Jilma & Martha M. Eibl. (2020) High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm. Toxins 12:10, pages 640.
Crossref
Crossref
Lei Xiu, Shouxin Sheng, Zhongpeng Hu, Yang Liu, Jianwei Li, Haochi Zhang, Yanchen Liang, Ruiping Du & Xiao Wang. (2020) Exopolysaccharides from Lactobacillus kiferi as adjuvant enhanced the immuno-protective against Staphylococcus aureus infection. International Journal of Biological Macromolecules 161, pages 10-23.
Crossref
Crossref
Jan T. Poolman. (2020) Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections. npj Vaccines 5:1.
Crossref
Crossref
Siyu Yang, Wanyu Li, Zhaowei Fan, Lu Zhai, Jing Chen, Xue Xiao, Jun Ma, Baifen Song, Jinzhu Ma, Chunyu Tong, Liquan Yu, Yongzhong Yu, Weifan Cao & Yudong Cui. (2020) Identification of CD4+ T cell epitopes on glyceraldehyde-3-phosphate dehydrogenase-C of Staphylococcus aureus in Babl/c mice. Microbial Pathogenesis 144, pages 104167.
Crossref
Crossref
Ming Zhao, Chunjun Qin, Lingxin Li, Haotian Xie, Beining Ma, Ziru Zhou, Jian Yin & Jing Hu. (2020) Conjugation of Synthetic Trisaccharide of Staphylococcus aureus Type 8 Capsular Polysaccharide Elicits Antibodies Recognizing Intact Bacterium. Frontiers in Chemistry 8.
Crossref
Crossref
Youhui Si, Fan ZhaoPavani BeesettyDaniela Weiskopf, Zhaotao LiQiaomu Tian, Maria-Luisa Alegre, Alessandro Sette, Anita S. Chong & Christopher P. Montgomery. (2020)
Inhibition of protective immunity against
Staphylococcus aureus
infection by MHC-restricted immunodominance is overcome by vaccination
. Science Advances 6:14.
Crossref
Crossref
Hao Zeng, Feng Yang, Qiang Feng, Jinyong Zhang, Jiang Gu, Haiming Jing, Changzhi Cai, Liming Xu, Xi Yang, Xin Xia, Ni Zeng, Shaowen Fan & Quanming Zou. (2020) Rapid and Broad Immune Efficacy of a Recombinant Five-Antigen Vaccine against Staphylococcus aureus Infection in Animal Models. Vaccines 8:1, pages 134.
Crossref
Crossref
Archanamayee Behera, Diksha Rai & Suvarn S. Kulkarni. (2019)
Total Syntheses of Conjugation-Ready Trisaccharide Repeating Units of
Pseudomonas aeruginosa
O11 and
Staphylococcus aureus
Type 5 Capsular Polysaccharide for Vaccine Development
. Journal of the American Chemical Society 142:1, pages 456-467.
Crossref
Crossref
Helen S. Marshall, James Baber, Peter Richmond, Michael Nissen, Sepehr Shakib, Barry N. Kreiswirth, Edward T. Zito, Joseph Severs, Joseph Eiden, William Gruber, Kathrin U. Jansen, C. Hal Jones & Annaliesa S. Anderson. (2019) S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine. Journal of Infection 79:6, pages 582-592.
Crossref
Crossref
Carmela Irene, Laura Fantappiè, Elena Caproni, Francesca Zerbini, Andrea Anesi, Michele Tomasi, Ilaria Zanella, Simone Stupia, Stefano Prete, Silvia Valensin, Enrico König, Luca Frattini, Assunta Gagliardi, Samine J. Isaac, Alberto Grandi, Graziano Guella & Guido Grandi. (2019)
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Staphylococcus aureus
vaccine
. Proceedings of the National Academy of Sciences 116:43, pages 21780-21788.
Crossref
Crossref
Rie Glerup, My Svensson, Jens D. Jensen & Jeppe H. Christensen. (2019) Staphylococcus aureus Bacteremia Risk in Hemodialysis Patients Using the Buttonhole Cannulation Technique: A Prospective Multicenter Study. Kidney Medicine 1:5, pages 263-270.
Crossref
Crossref
Tina Z. Wang, Rosy Priya L. Kodiyanplakkal & David P. Calfee. (2019) Antimicrobial resistance in nephrology. Nature Reviews Nephrology 15:8, pages 463-481.
Crossref
Crossref
Tarcisio Brignoli, Andrea G. O. Manetti, Roberto Rosini, Andreas F. Haag, Vincenzo Scarlato, Fabio Bagnoli & Isabel Delany. (2019) Absence of Protein A Expression Is Associated With Higher Capsule Production in Staphylococcal Isolates. Frontiers in Microbiology 10.
Crossref
Crossref
Dina Raafat, Michael Otto, Kevin Reppschläger, Jawad Iqbal & Silva Holtfreter. (2019) Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies. Trends in Microbiology 27:4, pages 303-322.
Crossref
Crossref
Eóin C. O’Brien & Rachel M. McLoughlin. (2019) Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development. Trends in Molecular Medicine 25:3, pages 171-184.
Crossref
Crossref
Roisin Connolly, Mark D. Denton, Hilary Humphreys & Rachel M. McLoughlin. (2019) Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?. Kidney International 95:3, pages 518-525.
Crossref
Crossref
D P R Troeman, D Van Hout & J A J W Kluytmans. (2019)
Antimicrobial approaches in the prevention of
Staphylococcus aureus
infections: a review
. Journal of Antimicrobial Chemotherapy 74:2, pages 281-294.
Crossref
Crossref
William Jiranek, James W.M. Kigera, Brian A. Klatt, Fatih Küçükdurmaz, Jay Lieberman, Claus Moser, Kevin Mulhall, Hasan Nahouli, Edward Schwarz, Noam Shohat & Majd Tarabichi. (2019) General Assembly, Prevention, Host Risk Mitigation - General Factors: Proceedings of International Consensus on Orthopedic Infections. The Journal of Arthroplasty 34:2, pages S43-S48.
Crossref
Crossref
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, Eduardo Rojas, Li Hao, Natalie C. Silmon de Monerri, Julio Hawkins, Guy Singh, Bing Cai, Paul Liberator, Shite Sebastian, Robert G. K. Donald, Ingrid L. Scully, C. Hal Jones, C. Buddy Creech, Isaac Thomsen, Julian Parkhill, Sharon J. Peacock, Kathrin U. Jansen, Matthew T. G. Holden & Annaliesa S. Anderson. (2019) Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States. PLOS ONE 14:1, pages e0208356.
Crossref
Crossref
Serena Manara, Edoardo Pasolli, Daniela Dolce, Novella Ravenni, Silvia Campana, Federica Armanini, Francesco Asnicar, Alessio Mengoni, Luisa Galli, Carlotta Montagnani, Elisabetta Venturini, Omar Rota-Stabelli, Guido Grandi, Giovanni Taccetti & Nicola Segata. (2018) Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital. Genome Medicine 10:1.
Crossref
Crossref
Philip S. BarieMayur NarayanRobert G. Sawyer. (2018)
Immunization Against
Staphylococcus aureus
Infections
. Surgical Infections 19:8, pages 750-756.
Crossref
Crossref
Fan Zhang, Olivia Ledue, Maria Jun, Cibelly Goulart, Richard Malley & Ying-Jie Lu. (2018) Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms. mBio 9:5.
Crossref
Crossref
Assaf Raz, Anna Serrano, Maneesha Thaker, Tricia Alston & Vincent A. Fischetti. (2018) Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Crossref
Georges Kosmadakis, Julie Albaret, Enrique Da Costa Correia, Frederic Somda & Didier Aguilera. (2018) Vaccination practices in dialysis patients: A narrative review. Seminars in Dialysis 31:5, pages 507-518.
Crossref
Crossref
Christopher D. Dupont, Ingrid L. Scully, Ross M. Zimnisky, Brinda Monian, Christina P. Rossitto, Ellen B. O'Connell, Kathrin U. Jansen, Annaliesa S. Anderson & J. Christopher Love. (2018)
Two Vaccines for
Staphylococcus aureus
Induce a B-Cell-Mediated Immune Response
. mSphere 3:4.
Crossref
Crossref
Francesco Berti, Riccardo De Ricco & Rino Rappuoli. (2018) Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines. Molecules 23:6, pages 1340.
Crossref
Crossref
Francesca Micoli, Paolo Costantino & Roberto Adamo. (2018) Potential targets for next generation antimicrobial glycoconjugate vaccines. FEMS Microbiology Reviews 42:3, pages 388-423.
Crossref
Crossref
Krystle A. Blanchette & Joseph C. Wenke. (2018) Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections. Journal of Bone and Joint Infection 3:2, pages 50-67.
Crossref
Crossref
Yuling Wu, Xu Liu, Ahmad Akhgar, Jia J. Li, Hoyin Mok, Bret R. Sellman, Li Yu, Lorin K. Roskos, Mark T. Esser & Alexey Ruzin. (2018) Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations. Infection and Immunity 86:3.
Crossref
Crossref
Wei Yu, Di Yao, Simiao Yu, Xintong Wang, Xiaoting Li, Mengyao Wang, Shuo Liu, Zhenyue Feng, Xiaoting Chen, Wanyu Li, Lizi Wang, Wei Liu, Jinzhu Ma, Liquan Yu, Chunyu Tong, Baifen Song & Yudong Cui. (2018) Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model. Scientific Reports 8:1.
Crossref
Crossref
Stephen P. Lockhart, Daniel A. Scott, Kathrin U. Jansen, Annaliesa S. Anderson & William C. Gruber. 2018. Carbohydrate-Based Vaccines: From Concept to Clinic. Carbohydrate-Based Vaccines: From Concept to Clinic
7
59
.
Robert S. Daum. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
692
706.e4
.
Robert S. Daum. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1031
1038.e4
.
Marie-Paule Gustin, Robin Ohannessian, Marine Giard, Emmanuelle Caillat-Vallet, Anne Savey & Philippe Vanhems. (2017) Use of surveillance data to calculate the sample size and the statistical power of randomized clinical trials testing Staphylococcus aureus vaccine efficacy in orthopedic surgery. Vaccine 35:50, pages 6934-6937.
Crossref
Crossref
A. Gagneux-Brunon, F. Lucht, O. Launay, P. Berthelot & E. Botelho-Nevers. (2017) Les vaccins dans la prévention des infections associées aux soins. Journal des Anti-infectieux 19:3-4, pages 134-146.
Crossref
Crossref
P. Loubet & O. Launay. (2017) Vaccination de l’adulte : données générales, actualités et perspectives. La Revue de Médecine Interne 38:11, pages 749-759.
Crossref
Crossref
Fan Zhang, Maria Jun, Olivia Ledue, Muriel Herd, Richard Malley & Ying-Jie Lu. (2017) Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine. Vaccine 35:31, pages 3834-3843.
Crossref
Crossref
Jason P. Burnham & Marin H. Kollef. (2017) Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won’t Cut It. Clinical Infectious Diseases 64:8, pages 1089-1091.
Crossref
Crossref
Farjana Khatun, Rachel J. Stephenson & Istvan Toth. (2017) An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity. Chemistry - A European Journal 23:18, pages 4233-4254.
Crossref
Crossref
Zinaida Polonskaya, Shenglou Deng, Anita Sarkar, Lisa Kain, Marta Comellas-Aragones, Craig S. McKay, Katarzyna Kaczanowska, Marie Holt, Ryan McBride, Valle Palomo, Kevin M. Self, Seth Taylor, Adriana Irimia, Sanjay R. Mehta, Jennifer M. Dan, Matthew Brigger, Shane Crotty, Stephen P. Schoenberger, James C. Paulson, Ian A. Wilson, Paul B. Savage, M.G. Finn & Luc Teyton. (2017) T cells control the generation of nanomolar-affinity anti-glycan antibodies. Journal of Clinical Investigation 127:4, pages 1491-1504.
Crossref
Crossref
Elizabeth Begier, David Joshua Seiden, Michael Patton, Edward Zito, Joseph Severs, David Cooper, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson & Alejandra Gurtman. (2017) SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine 35:8, pages 1132-1139.
Crossref
Crossref
N Mohamed, M Y Wang, J-C Le Huec, U Liljenqvist, I L Scully, J Baber, E Begier, K U Jansen, A Gurtman & A S Anderson. (2017)
Vaccine development to prevent
Staphylococcus aureus
surgical-site infections
. British Journal of Surgery 104:2, pages e41-e54.
Crossref
Crossref
C. Buddy Creech, Robert W. FrenckJrJr, Eric A. Sheldon, David J. Seiden, Martin K. Kankam, Edward T. Zito, Douglas Girgenti, Joseph M. Severs, Frederick W. Immermann, Lisa K. McNeil, David Cooper, Kathrin U. Jansen, William Gruber, Joseph Eiden, Annaliesa S. Anderson & James Baber. (2017) Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial. Vaccine 35:2, pages 385-394.
Crossref
Crossref
Rajan P. Adhikari, Christopher D. Thompson, M. Javad Aman & Jean C. Lee. (2016) Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections. Vaccine 34:50, pages 6402-6407.
Crossref
Crossref
Helen Marshall, Michael Nissen, Peter Richmond, Sepehr Shakib, Qin Jiang, David Cooper, Denise Rill, James Baber, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, Edward T. Zito & Douglas Girgenti. (2016) Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study. Journal of Infection 73:5, pages 437-454.
Crossref
Crossref
Mathias W. Pletz, Julia Uebele, Karen Götz, Stefan Hagel & Isabelle Bekeredjian-Ding. (2016) Vaccines against major ICU pathogens: where do we stand?. Current Opinion in Critical Care 22:5, pages 470-476.
Crossref
Crossref
Jane M. Knisely, Baoying Liu, Ryan T. Ranallo & Lanling Zou. (2016) Vaccines for Healthcare-associated Infections: Promise and Challenge. Clinical Infectious Diseases 63:5, pages 657-662.
Crossref
Crossref
C. Tkaczyk, M. M. Hamilton, A. Sadowska, Y. Shi, C.S. Chang, P. Chowdhury, R. Buonapane, X. Xiao, P. Warrener, J. Mediavilla, B. Kreiswirth, J. Suzich, C. K. Stover & B. R. Sellman. (2016) Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease. mBio 7:3.
Crossref
Crossref
Annemarie Kuipers, Daphne A. C. Stapels, Lleroy T. Weerwind, Ya-Ping Ko, Maartje Ruyken, Jean C. Lee, Kok P. M. van Kessel & Suzan H. M. Rooijakkers. (2016) The Staphylococcus
aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis. Microbiology 162:7, pages 1185-1194.
Crossref
Crossref
Birgitte K. Giersing, Sana S. Dastgheyb, Kayvon Modjarrad & Vasee Moorthy. (2016) Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine 34:26, pages 2962-2966.
Crossref
Crossref
Julia Whitehouse, Amy Flaxman, Christine Rollier, Matthew K. O'Shea, Joanne Fallowfield, Michael Lindsay, Frances Gunner, Kyle Knox, David H. Wyllie & Yuko Yamaguchi. (2016) Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion. Vaccine 34:15, pages 1792-1799.
Crossref
Crossref
Barbara Bröker, Daniel Mrochen & Vincent Péton. (2016) The T Cell Response to Staphylococcus aureus. Pathogens 5:1, pages 31.
Crossref
Crossref
Meritxell García-Quintanilla, Marina R. Pulido, Marta Carretero-Ledesma & Michael J. McConnell. (2016) Vaccines for Antibiotic-Resistant Bacteria: Possibility or Pipe Dream?. Trends in Pharmacological Sciences 37:2, pages 143-152.
Crossref
Crossref
Francesca Mancini, Elisabetta Monaci, Giuseppe Lofano, Antonina Torre, Marta Bacconi, Simona Tavarini, Chiara Sammicheli, Letizia Arcidiacono, Bruno Galletti, Donatello Laera, Michele Pallaoro, Giovanna Tuscano, Maria Rita Fontana, Giuliano Bensi, Guido Grandi, Silvia Rossi-Paccani, Sandra Nuti, Rino Rappuoli, Ennio De Gregorio, Fabio Bagnoli, Elisabetta Soldaini & Sylvie Bertholet. (2016) One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. PLOS ONE 11:1, pages e0147767.
Crossref
Crossref
Christine Selton-Suty, Olivier Huttin, François Goehringer & Luc Frimat. 2016. Infective Endocarditis. Infective Endocarditis
259
271
.
Clarissa Pozzi, Reuben Olaniyi, Lassi Liljeroos, Ilaria Galgani, Rino Rappuoli & Fabio Bagnoli. 2017. Staphylococcus aureus. Staphylococcus aureus
491
528
.
Reuben Olaniyi, Clarissa Pozzi, Luca Grimaldi & Fabio Bagnoli. 2017. Staphylococcus aureus. Staphylococcus aureus
199
227
.
Elisabetta Monaci, Francesca Mancini, Giuseppe Lofano, Marta Bacconi, Simona Tavarini, Chiara Sammicheli, Letizia Arcidiacono, Monica Giraldi, Bruno Galletti, Silvia Rossi Paccani, Antonina Torre, Maria Rita Fontana, Guido Grandi, Ennio de Gregorio, Giuliano Bensi, Emiliano Chiarot, Sandra Nuti, Fabio Bagnoli, Elisabetta Soldaini & Sylvie Bertholet. (2015) MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Frontiers in Immunology 6.
Crossref
Crossref
Susan Boyle-Vavra, Xue Li, Md Tauqeer Alam, Timothy D. Read, Julia Sieth, Colette Cywes-Bentley, Ginette Dobbins, Michael Z. David, Neha Kumar, Samantha J. Eells, Loren G. Miller, David J. Boxrud, Henry F. Chambers, Ruth Lynfield, Jean C. Lee & Robert S. Daum. (2015)
USA300 and USA500 Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the
cap5
Locus
. mBio 6:2.
Crossref
Crossref
Christopher Weidenmaier & Jean C. Lee. 2017. Staphylococcus aureus. Staphylococcus aureus
57
93
.